Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

‍Dr. Shah on IVIG’s Impact on Infection Risk in R/R Myeloma

‍Selecting Between Guideline-Recommended Treatment Options for Transplant-Eligible Newly Diagnosed Mu

‍Real-World Observations on CAR T Therapy in Relapsed/Refractory Multiple Myeloma

‍Dr. Kaddoura on Challenges of Integrating Whole Genome Sequencing in Myeloma

‍Real-World Observations on CAR T Therapy in Relapsed/Refractory Multiple Myeloma

‍PERSEUS Trial Highlights: Dara-VRd vs VRd in Transplant-Eligible Newly Diagnosed Multiple Myeloma

‍Expert Views on Referrals and Challenges of CAR T in Early R/R MM

‍Dr. Siegel on the Present and Future Role of Mezigdomide in Multiple Myeloma

‍Future Directions Post-AURIGA: Daratumumab and Lenalidomide in Multiple Myeloma Treatment‍

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.